Daojing Li
Tianjin, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Duplicate - Corrigendum to "Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway" [J. Neuroimmunol. 299 (2016) 164-171].
Journal: Journal of neuroimmunology
Published: February 05, 2019
Corrigendum to "Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway" [J. Neuroimmunol. 299 (2016) 164-171].
Journal: Journal of neuroimmunology
Published: December 12, 2018
Upregulation of Microglial ZEB1 Ameliorates Brain Damage after Acute Ischemic Stroke.
Journal: Cell reports
Published: November 13, 2017
Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 12, 2017
Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: November 20, 2016
MicroRNA-15b Suppresses Th17 Differentiation and Is Associated with Pathogenesis of Multiple Sclerosis by Targeting O-GlcNAc Transferase.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 06, 2016
DDIT4 and Associated lncDDIT4 Modulate Th17 Differentiation through the DDIT4/TSC/mTOR Pathway.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 29, 2016
MicroRNA-132 attenuates neurobehavioral and neuropathological changes associated with intracerebral hemorrhage in mice.
Journal: Neurochemistry international
Published: September 14, 2016
Everolimus (RAD001) ameliorates vascular cognitive impairment by regulating microglial function via the mTORC1 signaling pathway.
Journal: Journal of neuroimmunology
Published: June 27, 2016
Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury.
Journal: Journal of neuroinflammation
Published: December 26, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026